Remove Big Data Remove Clinical Research Remove Research Remove Trials
article thumbnail

Recognizing the Real People Behind the Big Data and Artificial Intelligence in Clinical Research

ACRP blog

If you hadn’t already noticed, the clinical research enterprise has well and truly entered the era of “big data,” artificial intelligence (AI), and machine learning. As a result, the time required to design, launch, and execute high-impact clinical trials is significantly reduced.”

article thumbnail

ACRP Journal Article Focuses on Clinical Research in Transgender and Gender Diverse Populations

ACRP blog

Just in time to help recognize Pride Month , ACRP’s Clinical Researcher journal is pleased to share the first details from the lead peer-reviewed article on “Improving Cardiovascular Research for Transgender and Gender Diverse Populations” from a trio of WCG IRB expert contributors to the new issue going online today (June 13).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

ACRP Journal Article Focuses on Clinical Research in Transgender and Gender Diverse Populations

ACRP blog

Just in time to help recognize Pride Month , ACRP’s Clinical Researcher journal is pleased to share the first details from the lead peer-reviewed article on “Improving Cardiovascular Research for Transgender and Gender Diverse Populations” from a trio of WCG IRB expert contributors to the new issue going online today (June 13).

article thumbnail

AI, big data and deep real-world evidence – the challenges and opportunities

pharmaphorum

Real-world evidence (RWE) is emerging as an important area of research to reveal, in real time, new insights and innovations and is accelerating the development of new and innovative therapies and treatments to improve patient outcomes. The webinar will also cover: The challenges of RWE research and how they are being overcome.

Big Data 102
article thumbnail

August 16, 2023: In This Friday’s PCT Grand Rounds, the Draft Revision of the ICH Good Clinical Practice Guideline

Rethinking Clinical Trials

Landry is a professor of medicine and epidemiology at Oxford Population Health and deputy director of the University of Oxford’s Big Data Institute. ElZarrad is the director of the Office of Medical Policy in the FDA’s Center for Drug Evaluation and Research. Join the online meeting. Join the online meeting.

article thumbnail

June 26, 2023: NIMHD Director Discusses Ways Researchers Can Help Reduce Health Disparities

Rethinking Clinical Trials

Pérez-Stable, MD This year’s annual Steering Committee meeting for the NIH Pragmatic Trials Collaboratory featured health equity as a central topic of discussion. He recommended sitting down with people as equals to co-develop research. In an interview after his keynote presentation, Eliseo J.

Research 130
article thumbnail

Six Benefits of Using a Mobile App in Clinical Trials

Crucial Data Soutions

A paradigm shift is occurring in the clinical trials industry surrounding mobile technology, or more specifically, mobile health (mHealth) following the COVID-19 pandemic. Organizations are beginning to recognize the power mHealth has to positively affect their clinical trials and are implementing technologies at an increasing rate.